首页|调控小胶质细胞干预阿尔茨海默病的研究进展

调控小胶质细胞干预阿尔茨海默病的研究进展

扫码查看
阿尔茨海默病(Alzheimer's disease,AD)是世界上最常见的以痴呆为主要表现形式的神经退行性疾病.以免疫细胞小胶质细胞为靶点的病理调控在治疗AD方面显示出独特优势,能够在早期阻止AD的病理进展.本文首先概述小胶质细胞在AD发病机制中的作用,然后总结小胶质细胞在AD中与常见关键病理Aβ、tau蛋白、神经炎症以及能量代谢障碍的关系,最后综述基于小胶质细胞为靶点以逆转AD病理的可行干预策略,并探讨各项研究目前仍需要改进的问题,旨在加深对调控小胶质细胞干预AD病理的策略了解,为未来AD患者的早期干预和治疗提供新的思路.
Research advances in modulating microglia for intervening in Alzheimer's disease
Alzheimer's disease(AD)is the most common neurodegenerative disease in the world with dementia as its main manifestation.The pathological regulation strategies based on microglia in immune cells have shown their unique advantages in treating AD by preventing the pathological progression of AD at an early stage.This paper firstly introduces the role of microglia in the pathogenesis of AD,then summarizes the relationship between microglia and the common key pathologies of Aβ,tau proteins,neuroinflammation,and impaired energy metabolism in AD,and finally reviews feasible microglia-targeted intervention strategies against AD with some discussion about some current issues for improvement in each study,in the hope of deepening the understanding of strategies that regulate microglia to block AD pathology and providing some new ideas for the early intervention and treatment of AD patients in the future.

microgliaAlzheimer's diseasetauneuroprotection

常远、Mageta Samwel MAGETA、李倪博文、汤迎琦、李黄娟、钱程根

展开 >

中国药科大学药学院药剂系,南京 210009

小胶质细胞 阿尔茨海默病 tau 神经保护

国家自然科学基金项目江苏省优秀青年基金项目

82072069BK20220153

2024

中国药科大学学报
中国药科大学

中国药科大学学报

CSTPCD北大核心
影响因子:0.655
ISSN:1000-5048
年,卷(期):2024.55(5)